Best Life Sciences Companies in Caesarea, Israel
The 33 best Life Sciences companies in Caesarea, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: V-Wave.
Our analysis of 50 Life Sciences companies
$2.2b in tracked funding; 75% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Life Sciences companies in Caesarea
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | V-Wave Provider of implantable shunt to treat heart failure | $132M | 73 mo ago | Acquired | 66 | — | WordPressApple iCloud MailMicrosoft 365+16 | 232 patents Cardiac interventional devices: atrial shunts, pressure control, and hourglass stents | — |
| 2 | Caesarea Medical Electronics Infusion and syringe pump systems and accessories | $100M | 154 mo ago | Acquired | — | Anat Barak Co-Founder | — | — | — |
| 3 | BrainsGate Electrical stimulation therapy for CNS diseases | $97M | 70 mo ago | Series F | 22 | — | — | 61 patents Implantable neural stimulation devices and delivery mechanisms for therapeutic neuromodulation | — |
| 4 | Ossio Bone regeneration biocomposite 72Funding top 25%Growth top 28%Moat top 29%Patents top 31% All 10 signals ▾Fundingtop 25% Growthtop 28% Moattop 29% Patentstop 31% Innovationtop 35% Techtop 37% Talenttop 38% Newstop 45% Markettop 50% Globalbottom 37% Funding: Raised $61.4M across 5 rounds · 5 rounds over 8 yrs (0.6/yr) Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 72/100 | $61M | 8 mo ago | Series C | 74 | Orahn Preiss Bloom Founder & President | WordPress Block EditorWordPressMySQL+24 | 128 patents Orthopedic suture anchors and fiber‑reinforced biocomposite implants for tissue fixation | — |
| 5 | LifeBond Provider of absorbable surgical sealants and hemostats | $56M | 135 mo ago | Acqui-Hired | 44 | — | — | 90 patents Crosslinkable gelatin biomaterials for hemostasis, implant fixation, tissue scaffolds, drug delivery | — |
| 6 | XACT Robotics Provider of image-guided needle steering system for minimally invasive procedures such as biopsies and… | $55M | 83 mo ago | Series D | 16 | — | WordPress Block EditorWordPressBugHerd+19 | 121 patents Robotic-assisted minimally invasive surgical tool insertion and drape attachment systems | — |
| 7 | OrthoSpace Biodegradable balloon system for rotator cuff tear | $24M | 119 mo ago | Acquired | 6 | Assaf Dekel Co-Founder | — | — | — |
| 8 | CardiacSense Provider of sensor to monitor heart arrhythmia and vital signs | $14M | 76 mo ago | Series B | 40 | Eldad Shemesh Co-Founder And Ceo | WordPressMySQLPHP+11 | 58 patents Wearable cardiac and oxygen saturation monitoring devices for continuous physiological tracking | — |
| 9 | IceCure Medical Ultrasound-guided cryoblation to treat breast fibroadenomas | $14M | 74 mo ago | Public | 72 | Eyal Shamir CEO | WordPressMySQLPHP+25 | 62 patents Medical cryotherapy devices for tumor ablation using cryoprobes and cryogenic flow control. | — |
| 10 | ConTipi Medical Vaginal inserts for urinary incontinence | $11M | 95 mo ago | Seed | 7 | — | WordPressMySQLPHP+31 | 51 patents 3D pelvic floor therapeutic devices for prolapse and fecal incontinence treatment | — |
| 11 | Arineta Developing imaging solutions for cardiac care | $10M | 179 mo ago | Series A | 81 | Ehud Dafni CEO | WordPress Block EditorElementorWordPress+24 | 58 patents CT image reconstruction and scatter correction for medical imaging systems | — |
| 12 | Cardiodex Disposable solutions for closing arterial access sites | $6M | 256 mo ago | Series A | — | Shimon Eckhouse Founder | — | 41 patents Patents concentrated in health & consumer products | — |
| 13 | Israel Biomedical Innovations Surgical soft tissue fastener for pelvic organ prolapse & a bladder fixation device | $3M | 201 mo ago | Acqui-Hired | 11 | Asaf Alperovitz CEO | — | 29 patents Innovative surgical fasteners with snap‑lock and mesh‑retention mechanisms for tissue closure | — |
| 14 | Newpace A subcutaneous cardioverter defibrillator which can be implanted minimally invasively | $3M | 67 mo ago | Funding Raised | 10 | Gera Strommer co-Founder | — | 87 patents Wearable, flexible cardiac defibrillation and implantable medical device technologies. | — |
| 15 | Upstream Peripheral Technologies Developed vascular intervention devices | $500K | — | Acquired | — | Scott Drake CEO | — | 16 patents Peripheral vascular access tools: sharp needle reentry and obstruction‑crossing catheter devices | — |
| 16 | Allevetix Developer of device for controlling hormonal balance | $116K | 97 mo ago | Funding Raised | — | Ziv Kalfon CEO | — | — | — |
Top 12 Life Sciences companies in Caesarea
#1
Series C · Caesarea, Haifa District · founded 2014 · 74 employees$61.4Mraised▾
Ossio focuses on orthopedic fixation using bone regeneration technology. The company has developed OSSIOfiber, a biocomposite material platform that contains reinforcing synthetic bone fibers and bioabsorbable polymer resin. The fiber provides mechanical strength and the resin provides binding property and promotes bone growth.
- Feb 2026Conventional Debt$50M
- Dec 2024Series C$27.6M
- Oct 2022Series C$38.5M
- Mar 2019Series A$22M
#2
Acquired · Caesarea, Haifa District · founded 2009 · 66 employees$132.5Mraised▾
V-Wave develops percutaneous implantable devices for treating patients with chronic Heart Failure. The compnay offers products like human implantable an inter-atrial shunt aimed at relieving symptoms and treating heart failure by controlling the left atrial pressure. The product is FDA approved.
- Sep 2020Series C$28M
- 2017Series C$70M
- Jan 2016Series B$28M
- Jul 2013Series A$2M
#3
Series F · Caesarea, Haifa District · founded 2000 · 22 employees$97Mraised▾
BrainsGate is developing a platform technology for electrical stimulation of the sphenopalatine ganglion (SPG), a nervous center known to increase cerebral blood flow. Focus application is acute ischemic stroke. Has developed an implantable electrode which can be activated through an external system temporarily attached to the patient's cheek.
- Dec 2020Series F$14M
- Jan 2015Series C$11M
- Aug 2011Series C$20M
- Aug 2008Series C$27.5M
#4
Series D · Caesarea, Haifa District · founded 2013 · 16 employees$55Mraised▾
Provider of image-guided needle steering system for minimally invasive procedures such as biopsies and ablations. It comprises of a robot based on S-Drive technology which enables the system to adapt from a linear to a non-linear trajectory to access tumors, lesions, or tissue samples.
- Nov 2019Series D$36M
- Jun 2018Series C$5M
- Mar 2017Series A$5M
- Aug 2015Series A$5M
#5
Acquired · Caesarea, Haifa District · founded 1993$100Mraised▾
Caesarea Medical Electronics develops and manufactures medical infusion delivery products for hospital and homecare needs. Products include volumetric infusion pump, syringe pumps and adminstrative sets for use in a wide range of applications. Founded by Zvi Barak and his wife Anat.
- Dec 2013PE$100M
#6
Acqui-Hired · Caesarea, Haifa District · founded 2007 · 44 employees$56.5Mraised▾
LifeBond is developing a line of absorbable surgical sealants and hemostats for preventing leakage and bleeding. The company flagship product, the LifeSeal SLR, is used as a sealant indicated for reinforcement of gastrointestinal, colorectal, and bariatric anastomoses. Its products also include LifeMesh Self-Fixating Mesh that provides secure surgical mesh fixation for inguinal and ventral hernia repair procedures. The company has received CE Mark and FDA approval for its products.
- Aug 2015Series D$27M
- May 2011Series C$20M
- Jun 2009Series B$8M
- Sep 2007Series A$1.5M
#7
Public · Caesarea, Haifa District · founded 2006 · 72 employees$14Mraised▾
IceCure Medical (previously known as Arbel Medical) develops and markets minimally invasive cryoablation therapies for women’s health. Flagship IceSense3 system provides a minimally invasive, in-office treatment for symptomatic breast fibroadenoma. It uses ultrasound imaging to guide a small probe into the fibroadenoma. The system then uses cold temperatures to ablate the targeted fibroadenoma.
- Aug 2020Post IPO$7M
- Feb 2015Post IPO$5.5M
- Nov 2013Post IPO$4M
- Jul 2008Series B$1M
#8
Series B · Caesarea, Haifa District · founded 2012 · 40 employees$14.5Mraised▾
Provider of sensor to monitor heart arrhythmia and vital signs. It develops medical sensors that can continuously monitor and diagnose patients non-invasively, over the wrist. It can be used to monitor cardiac arrest, atrial fibrillation, and vital signs.
- Jun 2020Series B$6M
- May 2019Series A$3.5M
- Mar 2019Grant (prize money)$56.1K
- Dec 2018Grant (prize money)$56.6K
#9
Acquired · Caesarea, Haifa District · founded 2009 · 6 employees$23.6Mraised▾
OrthoSpace develops and commercializes a biodegradable balloon system, InSpace, which is deployed using minimally invasive techniques. The shoulder is a complicated joint that requires the interconnected functioning of tendons, ligaments and bones. The InSpace Balloon, which is implanted between the acromion and the humeral head, creates a space between the bone structures(acromion and humeral head), allowing smooth and frictionless gliding. The system is designed to create a physical barrier between tissues in the subacromial space. The company claims that the InSpace biodegradable balloon system emulates the activity of the normal bursa and offers patients less pain, and a shorter rehabilitation period. As of 2016, The InSpace System has the CE mark and is commercially available in Europe.
- Dec 2016Series B$7M
- May 2015Series B$8M
- Jul 2013Series B$5M
- May 2011Series A$2.6M
#10
Seed · Caesarea, Haifa District · founded 2002 · 7 employees$11Mraised▾
ConTipi is focussed on developing a series of disposable vaginal inserts for the reduction & prevention of urinary incontinence. It is developing its products which can be inserted with an applicator and can provide flexible to adapt to different positions during exercise or movement and provide proper support to the urethra. It is also developing its second line of products called SporTIPI for use during strenuous exercise and physical exertion. As of October 2016, the product development details are not yet disclosed.
- Nov 2018Seed$3M
#11
Funding Raised · Caesarea, Haifa District · founded 2012 · 10 employees$3.1Mraised▾
NEWPACE is developing a subcutaneous cardioverter defibrillator which can be implanted minimally invasively. The device has a low-profile string-like shape with a rechargeable ICD and secure BLE communication for easy monitoring and interaction with other implanted devices. Its a development stage product as of June, 2016.
- Mar 2021Grant (prize money)$58.7K
- Jul 2018Grant (prize money)$2.9M
- Feb 2018Grant (prize money)$61.5K
- Nov 2017Grant (prize money)$58.1K
#12
Series A · Caesarea, Haifa District · founded 2006 · 81 employees$10Mraised▾
Arineta is a focussed on developing imaging solutions for cardiac care covering diagnostics and therapeutic applications. Based on its proprietary technologies, it is currently developing a CT scanner that claims to provide high resolution, motion-free, artifact-free, volumetric images of the whole heart. In addition to the imaging of the heart, it is also working on optimizing the design for other cardiovascular studies such as studies of the aorta, the carotid and renal arteries.
- Nov 2011Series A$10M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.